Our philosophy

Fortuna Clinical is fully dedicated to clinical trials services that are concentrated primarily in the medical device industry focusing on new product market entries on a worldwide basis, with a particular focus on Europe and USA.

Fortuna Clinical provides all services necessary for clinical trials including:

We love our customers and welcome your feedback and suggestions. Use our Contact Us page to tell us what we’re doing right or what we can improve on.

Our philosophy is to go beyond and above what one can expect from a “regular CRO”. We “dig deep” into each enrolling site performing procedures/surgeries, and conduct a throughout evaluation of each center regarding case mix and patient selection, regulatory environment, volume assessment, and safety assessment. We also provide referral marketing services, in situations where operators may need a boost in their enrollment. Fortuna Clinical has sound clinical and business contacts in Europe and all of our investigators are on our “speed dial”.

Leadership Team

Jan P. Skowronski, MD, MBA

Dr. Jan Skowronski is a native of Poland and he has completed his Medical School in Poland, London and Chicago. He received his medicine residency and cardiology fellowship at the University of Minnesota, and interventional cardiology fellowship at the University of Maryland. Dr. Skowronski is also a graduate of University of Illinois MBA program. Since 2006 he has served as the Director of the Cath Lab at St. Anthony Medical Center in Rockford, IL. He serves as Assistant Professor at The University of Illinois, College of Medicine.

He has been a participant in over 30 device and pharmaceutical trials. He is one of the highest volume interventional cardiologists in Illinois and he performs Transcatheter Aortic Valve Replacement, LAA occlusion, Critical and Acute Limb Ischemia cases, Carotid Artery Stenting, and wide variety of advanced coronary and endovascular work. He has served as a consultant for multiple device and pharma companies and contributed to development of new cardiovascular devices. He is a gifted speaker on multiple device related topics and has served multiple times as a hands-on proctor for advanced endovascular procedures in the U.S. and in Europe.

Steven S. Brooks, MD, MBA

Dr. Steven S. Brooks is a multi-faceted clinical trialist, publisher, and interventional cardiologist.

For six years Dr. Brooks was the sole interventional cardiologist serving as a Medical Officer at the FDA focusing there on Endovascular Devices, Medical Devices Reimbursement and Innovation. He is highly recognized throughout the global medical community for his expertise in clinical trial design & execution, and regulatory processes. He has delivered multiple presentations at major life-sciences meetings, has conducted numerous educational programs and served as a panelist on many international conferences.

Dr. Brooks received his MD degree from the University of Pittsburgh, School of Medicine. He earned a Business of Medicine Graduate Certificate and a MBA degree from the Johns Hopkins University Carey School of Business. He completed his medical training at the University of Pittsburgh, and served as interventional cardiologist at the University of Maryland Medical Center.

Ewa Puczylowska-Marszalek, MD

Dr. Ewa Marszalek has over 15 years of medical devices and pharmaceutical technologies industries experience. During the last 15 years Dr. Marszalek led, managed, and conducted over 40 clinical trials in Eastern Europe. She is certified in Clinical Research Management by CRDE.

Dr. Marszalek received her Medical Degree from the Silesian University of Medicine, and is Board Certified in Radiology. She held the position of The Director of Imaging Department at Regional Trauma Surgery Hospital in Piekary Śląskie and was consulting radiologist at Radiology Department in Municipal Hospital in Piekary Śląskie, Poland. Prior to joining Fortuna Clinical Dr. Marszalek worked as a senior executive at leading Polish CROs.